1-17044824-C-T
Variant summary
The NM_003000.3(SDHB):c.137G>A (p.Arg46Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000167 (AC=27) in the gnomAD database across 1,613,850 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000121. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000212994: This mutation has been shown to increase protein degradation and to reduce mutant protein half-life in transfected cell lines (Saxena N et al. J. Natl. Cancer Inst. 2016 Jan;108" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R46G: Pathogenic (ClinVar VariationId 12785, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R46?: Uncertain_significance (ClinVar VariationId 591278, 0 stars); p.R46P: Uncertain_significance (ClinVar VariationId 3756934, 1 star); p.R46= (synonymous): Likely_benign (ClinVar VariationId 1100244, 1 star); p.R46= (synonymous): Benign/Likely_benign (ClinVar VariationId 646758, 2 stars); p.R46= (synonymous): Likely_benign (ClinVar VariationId 937404, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_003000.3 missense
Scores
Clinical Significance
Conservation
Publications
- Carney-Stratakis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial complex II deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 15 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000212994: This mutation has been shown to increase protein degradation and to reduce mutant protein half-life in transfected cell lines (Saxena N et al. J. Natl. Cancer Inst. 2016 Jan;108; Yang C et al. FASEB J, 2012 Nov;26:4506-16). In addition, in vitro analyses have shown significantly reduced mitochondrial SDHB expression and a reduction in SDHB enzymatic activity compared to wild type (Kim E et al. Endocr. Relat. Cancer. 2015 Jun;22:387-97). Functional analysis of R46Q demonstrated complete loss of SDHB-SDHAF3 interaction (Dwight T et al. BMC Cancer, 2017 Jul;17:497). Structural analysis showed that the R46Q alteration impaired iron incorporation and Complex II biogenesis (Maio N et al. Cell Metab, 2014 Mar;19:445-57).; SCV000235637: "Published functional studies demonstrate a damaging effect: reduced protein stability, decreased succinate dehydrogenase activity, and increased hypoxia-inducible factors (Giminez-Roqueplo et al., 2002; Yang et al., 2012; Saxena et al., 2015)"; SCV000886095: Further, functional analyses of p.Arg46Gln demonstrate decreased succinate dehydrogenase expression and activity and increased hypoxia-inducible factors (Saxena 2016).; SCV004045422: Functional studies indicate this variant impacts protein function [PMID: 22677546, 26719882, 25972245].; SCV004362282: "Functional studies have shown that this variant results in decreased mitochondrial expression, decreased succinate dehydrogenase activity, and reduced interaction with SDHA and SDHAF3 (PMID: 22835832, 23175444, 24606901, 25972245, 26719882, 28738844)."; SCV004821943: "Functional studies have shown that this variant results in decreased mitochondrial expression, decreased succinate dehydrogenase activity, and reduced interaction with SDHA and SDHAF3 (PMID: 22835832, 23175444, 24606901, 25972245, 26719882, 28738844)."; SCV000287759: Experimental studies have shown that this missense change affects SDHB function (PMID: 22835832, 25972245, 26719882).; SCV005358433: Functional in vitro assays show that this variant leads to protein instability (Yang et al. 2012. PubMed ID: 22835832; Saxena et al. 2016. PubMed ID: 26719882). | ||
| PM1Mutational hot spot or critical domain | UniProt domain with ≥4 pathogenic missense and OR ≥ 5 vs. background — hotspot (PM1); In-domain: 121 pathogenic, 13 benign rare missense variants (OR vs. background: 45.0).; ±8 AA neighbourhood: 5 pathogenic, 2 benign (OR vs. background: 11.0). | ||
| PM2Absent/extremely low in population databases | Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.0000121 — borderline rare for AD+AR gene (threshold 0.0001) — PM2 supporting. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R46G: Pathogenic (ClinVar VariationId 12785, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.R46?: Uncertain_significance (ClinVar VariationId 591278, 0 stars); p.R46P: Uncertain_significance (ClinVar VariationId 3756934, 1 star); p.R46= (synonymous): Likely_benign (ClinVar VariationId 1100244, 1 star); p.R46= (synonymous): Benign/Likely_benign (ClinVar VariationId 646758, 2 stars); p.R46= (synonymous): Likely_benign (ClinVar VariationId 937404, 1 star) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (25/25 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003000.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | MANE Select | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: NP_002991.2 UniProt: | |
SDHB | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: NP_001394290.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | TSL:1MANE Select | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: ENSP00000364649.3 UniProt: | |
SDHB | c.182G>A p.Arg61Gln | missense | Exon 3 of 9 | Prot: ENSP00000519325.1 UniProt: | ||
SDHB | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: ENSP00000595680.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000132 | AC:2 | Hom:0 | AN:152060 | Cov:32 |
GnomAD2 exomes | AF: 0.00000398 | AC:1 | AN:251358 | ||
GnomAD4 exome | AF: 0.0000171 | AC:25 | Hom:0 | AN:1461790 | Cov:32 |
GnomAD4 genome | AF: 0.0000132 | AC:2 | Hom:0 | AN:152060 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000151 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000126 | AC:3 | Hom:0 | AN:238764 | |
Local & regional cohorts 2 sources | |||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000570 | AC:7 | Hom:0 | AN:122586 | |
UK10K | AF: 0.000264 | AC:2 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.0000352 | 1 | 28420 | 0.00 | 0 | 28844 |
Epi25 | 0.0000238 | 1 | 41958 | 0.0000299 | 2 | 66888 |
SCHEMA | 0.0000392 | 3 | 76580 | 0.00000751 | 1 | 133232 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 29 | |
AlphaMissense | Pathogenic | 0.93 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.58 | |
CADD | Pathogenic | 33 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Pathogenic | 0.93 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Pathogenic | 0.97 | |
GPN-Star LLR | N/A | -7.1 | |
GPN-Star score | N/A | 7.1 | |
LIST_S2 | Pathogenic | 1.0 | D |
M_CAP | Pathogenic | 0.57 | D |
MetaRNN | Pathogenic | 0.98 | D |
MetaSVM | Pathogenic | 0.95 | D |
Mutation Taster | N/A | 6/94 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.6 | H |
PhyloP100 | Uncertain | 7.1 | |
popEVE | Benign | -3.5 | |
PrimateAI | Uncertain | 0.55 | T |
PromoterAI | N/A | -0.023 | Neutral |
PROVEAN | Uncertain | -3.3 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.91 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0010 | D |
Varity_R | N/A | 0.94 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.